The COVID-19 pandemic may have played a considerable role in the uptick of adults being treated for ADHD. But more data is needed to determine whether the trends will continue.
Academic rigor, journalistic flair
Articles on Drug shortages
Displaying all articles
The shortages, which have been going on for years, have typically affected only low-cost generics rather than profitable brand-name drugs.
Ongoing shortages of the drug have been reported in the UK, Australi and Ireland.
These shortages are a result of rising demand and supply chain bottlenecks. But there are things that can be done to reduce harms to public health.
Many common medications – including those prescribed for menopause, dementia, and depression – are currently seeing shortages worldwide.
Current supply shortages may also be a problem for people in palliative care or receiving cancer treatment.
COVID-19 has resulted in higher than normal levels of medicine shortages. Here’s what to do if your local pharmacy is out of stock.
This is a pivotal time for policymakers to be vigilant about drug shortages and to ensure that Canadians have reliable access to safe drugs.
Shortages and high prices are making pharmaceuticals, often including generics, out of reach for millions of Americans.
The Canadian government must undertake regular analysis of the drug shortage problem, if we are ever to develop sustainable solutions.
The US is currently short on 182 drugs and medical supplies. The problem isn’t new, but it’s frustrating health care workers.
Although the medical profession must make hard choices about how to allocate care, these decisions need not and should not be shrouded in mystery.
Four years ago, just before Christmas, my hospital ran out of cytarabine, an essential drug used to treat and cure certain kinds of acute leukemia. This drug was suddenly in short supply across the nation…
Top contributors
-
Director of the Digital Health Enterprise Zone (DHEZ), University of Bradford, Professor of Health Service Operations, University of Bradford
-
Practice Pharmacist/Honorary Senior Research Fellow, University of Bradford
-
Associate Professor in Pharmacy Practice, University of Bradford
-
Professor of Pediatrics and Medicine Director of Clinical Ethics, Duke University Hospital, Duke University
-
Associate Dean for Research and Faculty Development and Professor of Law, College of Law, Georgia State University
-
Professor of Law and Director, Center for Law Health and Society, College of Law, Georgia State University
-
Professor of Health Law and Bioethics, Case Western Reserve University
-
Associate Professor, Faculty of Law and Cumming School of Medicine; Member, AMR One Health Consortium, University of Calgary
-
Professor Emerita in the Hannah Chair, History of Medicine, Queen's University, Ontario
-
Associate Professor of Health Policy and Cancer Research, Vanderbilt University
-
Assistant Professor, Community Health Sciences, Cumming School of Medicine, University of Calgary
-
Pharmacist and PhD Candidate, University of Sydney
-
Lecturer in Operations Management, Lancaster University
-
Director of Health Policy, USC Schaeffer Center, and Associate Professor, University of Southern California
-
Senior Lecturer in Operations Management, Department of Management Science, Lancaster University
